Drawing for STEDABLY

USPTO serial 88226914

STEDABLY

Reviewed by CopyMark Law Group

Reg. 5993770Status 710
Filing date
Status date
Registration date
Feb 25, 2020
Examiner
PAQUIN, SAMUEL ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with STEDABLY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony P. Venturino

Anthony P. Venturino Vorys, Sater, Seymour and Pease LLPIPLAW@VORYS -PO BOX 2255Columbus, OH 43216-2255UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, alimentary tract and metabolism problems, respiratory diseases, endocrine, musculoskeletal, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmological, otologicals, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders; Therapeutic cellular and stem cell compositions for clinical or medical useSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2026C8..CANCELLED SEC. 8 (6-YR)—
Feb 25, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 25, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 21, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jan 21, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 10, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Dec 10, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Aug 6, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 11, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 22, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
May 3, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 25, 2019ALIEASSIGNED TO LIE—
Apr 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 11, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 11, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 11, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 11, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 13, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2019DOCKASSIGNED TO EXAMINER—
Jan 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance